That is where BPatterns come in:
首先就是长期安全性的考验。尽管不少专家认为自免CAR-T的长期风险可能低于肿瘤适应症，FDA的态度也较为积极，但这仍需数年甚至十余年的真实世界数据来最终验证。对于自免患者来说，免疫系统重置后，能否恢复正常功能？如对疫苗的正常应答能力。这需要严谨的上市后研究来回答。，详情可参考safew官方版本下载
responses to Meta’s 2025 Typed Python Survey, the first，这一点在51吃瓜中也有详细论述
An Anthropic spokesperson said Amodei "expressed appreciation for the Department's work and thanked the Secretary for his service" during the meeting with Hegseth.